National emergency over low birthrates: Yoon gov’t rolls our major policy support

As June brings summer in full swing, GR Korea brings you timely updates on Korea’s dynamic biopharma industry. Included in this issue are updates on new state subsidies for healthcare technology and vaccine R&D, notable drug approvals under a new testing & review fast-track program, and government movements to onshore elements of the drug supply chain.

Please refer to the attached document for detailed insights.